Immunization Timetable
I. IAP recommended vaccines for routine use
|
|
|
Age |
Vaccines |
Comments |
| 1
|
AT BIRTH
|
BCG
OPV 0
Hep-B 1
|
Administer these vaccines to all newborns before hospital discharge
|
| 2
|
6 WEEKS
|
DTwP 1
IPV 1
Hep-B 2
Hib-1
Rotavirus-1
PCV-1 |
DTP:
- DTaP vaccine/combinations should preferably be avoided for the primary series
- DTaP vaccine/combinations should be preferred in certain specific circumstances/conditions only
- No need of repeating/giving additional doses of wholecell pertussis (wP) vaccine to a child who has earlier completed their primary schedule with acellular pertussis (aP) vaccine-containing products
Polio:
- All doses of IPV may be replaced with OPV if administration of the former is unfeasible
- Additional doses of OPV on all supplementary immunization activities (SIAs)
- Two doses of IPV instead of 3 for primary series if started at 8 weeks, and 8 weeks interval between the doses
- No child should leave the facility without polio immunization (IPV or OPV), if indicated by the schedule
See footnotes under figure titled IAP recommended immunization schedule (with range) for recommendations on intradermal IPV
Rotavirus:
- 2 doses of RV1 and 3 doses of RV5 & RV 116E
- RV1 should be employed in 10 & 14 week schedule, 10 & 14 week schedule of RV1 is found to be more immunogenic than 6 & 10 week schedule
|
| 3 |
10 WEEKS |
DTwP-2
IPV-2
Hib-2
Rotavirus-2
PCV-2
|
Rotavirus:
If RV1 is chosen, the first dose should be given at 10 weeks
|
| 4 |
14 WEEKS |
DTwP-3
IPV-3
Hib-3
Rotavirus-3
PCV-3
|
Rotavirus:
- Only 2 doses of RV1 are recommended.
- If RV1 is chosen, the 2nd dose should be given at 14 weeks
|
| 5 |
6 MONTHS |
OPV-1
Hep-B-3
|
Hepatitis-B:
The final (3rd or 4th ) dose in the HepB vaccine
series should be administered no earlier than age 24 weeks and
at least 16 weeks after the first dose.
|
| 6 |
9 MONTHS |
OPV-2
MMR-1
|
MMR:
- Measles-containing vaccine ideally should not be administered before completing 270 days or 9 months of life
- The 2nd dose must follow in 2nd year of life
- No need to give stand-alone measles vaccine
|
| 7 |
9-12 MONTHS |
Typhoid Conjugate Vaccine
|
- Currently, two typhoid conjugate vaccines, Typbar-TCV® and PedaTyph® available in Indian market; either can be used
- An interval of at least 4 weeks with the MMR vaccine should be maintained while administering this vaccine
|
| 8 |
12 MONTHS |
Hep-A-1 |
Hepatitis A:
- Single dose for live attenuated H2-strain Hep-A vaccine
- Two doses for all inactivated Hep-A vaccines are recommended
|
| 9 |
15 MONTHS |
MMR-2
Varicella-1
PCV-booster
|
MMR:
- The 2nd dose must follow in 2nd year of life
- However, it can be given at anytime 4-8 weeks after the 1st dose
Varicella:
The risk of breakthrough varicella is lower if given
15 months onwards
|
| 10 |
16-18 MONTHS |
DTwP-B1/DTaP-B1
IPV-B1
Hib-B1
|
The first booster (4thth dose) may be administered as early as
age 12 months, provided at least 6 months have elapsed since
the third dose.
DTP:
- 1st & 2nd boosters should preferably be of DTwP
- Considering a higher reactogenicity of DTwP, DTaP can be considered for the boosters
|
| 11 |
18 MONTHS |
Hep-A-2 |
Hepatitis A: 2nd dose for inactivated vaccines only
|
| 12 |
2 YEARS |
Booster of Typhoid
Conjugate Vaccine |
- A booster dose of Typhoid conjugate vaccine (TCV), if primary dose is given at 9-12 months
- A dose of Typhoid Vi-polysaccharide (Vi-PS) vaccine can be given if conjugate vaccine is not available or feasible
- Revaccination every 3 years with Vi-polysaccharide vaccine
- Typhoid conjugate vaccine should be preferred over Vi- PS vaccine
|
| 13 |
4-6 YEARS |
DTwP-B2/DTaP-B2
OPV-3
Varicella-2
MMR 3
|
Varicella: The 2nd dose can be given at anytime 3 months after the 1st dose.
MMR: The 3rd dose is recommended at 4-6 years of age.
|
| 14 |
10-12 YEARS |
Tdap/Td
HPV |
Tdap: is preferred to Td followed by Td every 10 years
HPV:
- Only 2 doses of either of the two HPV vaccines for adolescent/preadolescent girls aged 9-14 years;
- For girls 15 years and older and immunocompromised individuals, 3 doses are recommended
- For two-dose schedule, the minimum interval between doses should be 6 months.
- For 3 dose schedule, the doses can be administered at 0, 1-2 (depending on brand) and 6 months
|
|
II. IAP recommended vaccines for High-risk children (Vaccines under special circumstances):
|
- Influenza Vaccine
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Cholera Vaccine
- Rabies Vaccine
- Yellow Fever Vaccine
- Pneumococcal Polysaccharide vaccine (PPSV 23)
|
|
High-risk category of children:
|
- Congenital or acquired immunodeficiency (including HIV infection), Chronic cardiac, pulmonary (including asthma if treated with prolonged high-dose oral corticosteroids), hematologic, renal (including nephrotic syndrome), liver disease and diabetes mellitus
- Children on long term steroids, salicylates, immunosuppressive or radiation therapy
- Diabetes mellitus, Cerebrospinal fluid leak, Cochlear implant, Malignancies,
- Children with functional/ anatomic asplenia/ hyposplenia
- During disease outbreaks
- Laboratory personnel and healthcare workers
- Travelers
- Children having pets in home
- Children perceived with higher threat of being bitten by dogs such as hostellers, risk of stray dog menace while going outdoor.
|